Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

• Status: Completed
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Introduction: remifentanil's optimal dose for children intubation without neuromuscular blockade is unknown. Method: phase IV adaptative trial using Dixon's up-and-down method for modeling remifentanil's dose-response curve for adequate intubation conditions as defined by previous studies.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Brasilia University Hospital
• Collaborator: University of Brasilia
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• ASA I or II

• Scheduled for surgery under general anesthesia.

Exclusion Criteria:

• Predicted difficult airway

• Severe neurologic or cardiologic conditions

• Recent upper airway infectious diseases